MedTrace Logo

Study to Evaluate the Clinical Outcome in High Risk Patients Who Received Empirical Antifungal Therapy

NCT01439646 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2015-08-13

No results posted yet for this study

Summary

Retrospective, observational study To study the effect of Empirical Antifungal therapy on clinical outcome in high risk patients with suspected Invasive Fungal Infection admitted in ICU/Critical care unit, To know the current epidemiology of IFI and management approach in patients at high risk of Invasive fungal infections, Identify the risk factors associated with Invasive fungal infections, To comment on the appropriateness of empirical therapy used based on proven/probable diagnosis

Conditions

  • Antifungal Therapy

Interventions

OTHER

it is a retrospective study, hence no active intervention

since it is an observational restrospective study hence no active intervention is planned

Sponsors & Collaborators

Principal Investigators

  • raja dhar, MD · Fortis Hospital, Kolkata

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • India

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01439646 on ClinicalTrials.gov